FDA approves drug for night sweats
The Food and Drug Administration on Friday approved a new non-hormonal drug to treat hot flashes and night sweats that often affect people during menopause.While not as effective as standard treatment (estrogen or estrogen plus progestin), the new prescription drug, frezolinetant, will be welcomed by those struggling with vasomotor symptoms (episodes of intense heat along with sweating and hot flashes) and not will or cannot take hormone therapy, such as breast cancer survivors. The pills will be marketed as Veozah to treat moderate to severe hot flashes, the most common symptom caused by menopause It can last several years or…
